Accent Capital Management’s Merck MRK Stock Holding History

Accent Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.3K	Hold	420	–	–	0.02%	110
2026 Q1	$50.9K	Hold	420	–	–	0.02%	103
2025 Q4	$44.6K	Hold	420	–	–	0.02%	94
2025 Q3	$35.6K	Hold	420	–	–	0.01%	105
2025 Q2	$33.6K	Hold	420	–	–	0.02%	119
2025 Q1	$38K	Hold	420	–	–	0.02%	107
2024 Q4	$42.1K	Hold	420	–	–	0.02%	85
2024 Q3	$48K	Hold	420	–	–	0.03%	97
2024 Q2	$52K	Hold	420	–	–	0.03%	91
2024 Q1	$55.7K	Hold	420	–	–	0.05%	71
2023 Q4	$45.8K	Buy	+420	New	+$43.6K	0.04%	98

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Accent Capital Management's MRK Position: Q2 2026 in Review

Accent Capital Management held its Merck (MRK) position steady in Q2 2026 at 420 shares worth $54.3K. The position accounts for 0.02% of the portfolio, ranked #110.

Accent Capital Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $55.7K in Q1 2024. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Accent Capital Management held 420 shares of Merck worth $54.3K as of Q2 2026.
Accent Capital Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.02% of Accent Capital Management's portfolio in Q2 2026, its #110 holding.
Accent Capital Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Accent Capital Management's Merck position peaked at $55.7K in Q1 2024.
3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.